These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6166371)

  • 1. Isolation and characterization of an immunosuppressive acidic protein from ascitic fluids of cancer patients.
    Tamura K; Shibata Y; Matsuda Y; Ishida N
    Cancer Res; 1981 Aug; 41(8):3244-52. PubMed ID: 6166371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Suppression of immunological response by ascitic fluid from gastrointestinal cancer patients].
    Amemiya K
    Nihon Geka Gakkai Zasshi; 1983 Dec; 84(12):1229-36. PubMed ID: 6201709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of an immunosuppressive factor from malignant ascites that resembles a factor induced in vitro by carcinoembryonic antigen.
    Medoff JR; Clack VD; Roche JK
    J Immunol; 1986 Sep; 137(6):2057-64. PubMed ID: 3528293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification, properties and identification of a serum DNA binding protein (64DP) and its microheterogeneity.
    Tsuda M; Ohkubo T; Kamiguchi H; Suzuki K; Nakasaki H; Mitomi T; Katsunuma T
    Tokai J Exp Clin Med; 1982 Mar; 7(2):201-11. PubMed ID: 6808710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of a 14 kDa immunosuppressive protein derived from IIB-MEL-J, a human melanoma cell line.
    Morvillo V; Bover L; Mordoh J
    Cell Mol Biol (Noisy-le-grand); 1996 Jul; 42(5):779-95. PubMed ID: 8832109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterization of an immunosuppressive factor from ovarian cancer ascites fluid.
    Oh SK; Moolten FL
    Eur J Immunol; 1981 Oct; 11(10):780-8. PubMed ID: 6273181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppressive activity and tissue polypeptide antigen content of human ascitic fluids.
    Badger AM; Buehler RJ; Cooperband SR
    Cancer Res; 1978 Oct; 38(10):3365-70. PubMed ID: 688226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive activity of ascitic fluid from patients with cancer metastatic to the peritoneum.
    Badger AM; Cooperband SR; Merluzzi VJ; Glasgow AH
    Cancer Res; 1977 Apr; 37(4):1220-6. PubMed ID: 139204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterization of immunosuppressive (IS) substance obtained from ascitic fluids of patients with gastrointestinal cancer.
    Fujii M; Takahashi N; Hayashi H; Matsunaga K; Yoshikumi C
    Clin Biochem; 1987 Jun; 20(3):183-9. PubMed ID: 3652440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of alpha 1-acid glycoprotein molecular variants in ascitic fluid of cancer and non-cancer patients.
    Fujii M; Takahashi N; Hayashi H; Furusho T; Matsunaga K; Yoshikumi C
    Anticancer Res; 1988; 8(3):303-6. PubMed ID: 3389735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-1 acid glycoprotein is an immunosuppressive factor found in ascites from ovaria carcinoma.
    Elg SA; Mayer AR; Carson LF; Twiggs LB; Hill RB; Ramakrishnan S
    Cancer; 1997 Oct; 80(8):1448-56. PubMed ID: 9338469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and biochemical characterization of human liver-derived inhibitory protein (LIP).
    Grol M; Schumacher K
    J Immunol; 1983 Jan; 130(1):323-6. PubMed ID: 6401186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and characterization of a cellular protein-lipid complex from ascites fluid caused by various neoplasms.
    Caselmann WH; Jüngst D
    Cancer Res; 1986 Mar; 46(3):1547-52. PubMed ID: 3080244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of preoperative immunosuppressive acidic protein levels in patients with gastric carcinoma.
    Takeuchi H; Maehara Y; Tokunaga E; Koga T; Kakeji Y; Sugimachi K
    Hepatogastroenterology; 2003; 50(49):289-92. PubMed ID: 12630043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation, purification and identification of a serum DNA binding protein which increases in malignant diseases.
    Ohkubo T; Tsuda M; Yamamura M; Matsumoto M; Kamiguchi H; Katsunuma T
    Tokai J Exp Clin Med; 1982 May; 7(3):331-6. PubMed ID: 6896936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of PM-2 DNA degradation by a human serum protein.
    Galvan L; Evans JE; Huang CH; Prestayko A; Wu B; Crooke ST
    Cancer Res; 1982 Apr; 42(4):1555-61. PubMed ID: 6174227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification, physicochemical characterization, and antitumor activity of a cancer-associated human serum protein that is increased by treatment with schizophyllan, an antitumor polysaccharide.
    Akima K; Arika T; Amemiya K
    Jpn J Cancer Res; 1985 Jun; 76(6):541-8. PubMed ID: 3926585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The relationship between serum immunosuppressive acidic protein (IAP) and cellular immunity in the patients with gastric cancer].
    Nakanishi K; Toge T; Hamamoto S; Tanada M; Itagaki E; Kohno H; Yanagawa E; Hattori T
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1827-31. PubMed ID: 6223588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical evaluation of the serum level of immunosuppressive acidic protein (IAP) and immunosuppressive substance (IS) in gastric cancer patients].
    Sakita M; Yamane T; Kasuga M; Torii T; Imai H; Kageyama N; Fujita Y; Majima S
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1755-64. PubMed ID: 7184372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and partial characterization of a Mr 52,000 glycoprotein from human cancer ascites fluid which stimulates bone resorption in vitro.
    Lamkin MS; Colclasure C; Lloyd WS; Doherty JM; Gonnerman W; Schmid K; Nimberg RB
    Cancer Res; 1986 Sep; 46(9):4650-5. PubMed ID: 3731118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.